Article Details

A Case Report on Ulcerative Colitis with Interventional Outcomes

[ ISSN : 3067-977X ]

Abstract

Sandeep RJ¹, Hari HC², Jyothsna RD² and Mahender V²*

¹Department of Gastroenterology, Rohini Super Specialty Hospital, India
²Department of Pharmacy Practice, St. Peter’s Institute of Pharmaceutical Sciences, India

Corresponding Author:

Mahender V, Department of Pharmacy Practice, St.Peter’s Institute of Pharmaceutical Sciences, India, Email: mahi.reddy125@gmail.com

Keywords: Ulcerative colitis; Drugdrug interactions; Adverse effect; Colonoscopy

Abstract

Ulcerative Colitis (UC) is a mucosal disease that usually involves the rectum and extends proximally to involve all or part of the colon. Main causes are gut microbiota, dysregulation of the host’s immune system, genetic susceptibility and environmental factors. Active disease can be associated with a rise in acute phase reactants [C - reactive protein (CRP)], platelet count and Erythrocyte Sedimentation Rate (ESR) and a decrease in hemoglobin. Colonoscopy is used to assess disease activity and is often performed before treatment. In this case, recurrence UC was observed and it was treated with suitable therapy but some drug interactions like metronidizole additive effect with ofloxacin results in ST-T elevation and adverse effects like abdominal pain, burning pain in midsternal area radiating to epigastric region [Calcium+Vitamin-D] were seen. Those are monitored by the alternative therapy like dose management and drug alterations.

Citation

Sandeep RJ, Hari HC, Jyothsna RD and Mahender V. A Case Report on Ulcerative Colitis with Interventional Outcomes. J Gastroenterol. 2016; 2(1): 1004.

Download PDF

Received: October 15, 2016

Accepted: December 21, 2016

Published: December 28, 2016